Market Place
Sourcing Support
Fulgent Reports Q3 2024 Financial Results
08 Nov 2024 //
BUSINESSWIRE
Fulgent to Participate in Upcoming Conferences
05 Nov 2024 //
BUSINESSWIRE
Fulgent`s FID-007 Shows Antitumor Activity In Head And Neck Cancer
03 Jun 2024 //
BUSINESSWIRE
Fulgent Fid-007 Asco Presentation: Lead Oncology Candidate Clinical Data
24 May 2024 //
BUSINESSWIRE
Moffitt and Fulgent Pharma partner on personalised cancer therapies
15 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Fulgent Reports First Quarter 2024 Financial Results
03 May 2024 //
BUSINESSWIRE
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 2024 //
BUSINESSWIRE
Fulgent Reports Third Quarter 2023 Financial Results
03 Nov 2023 //
BUSINESSWIRE
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
03 Nov 2023 //
BUSINESSWIRE
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
25 Oct 2023 //
BUSINESSWIRE
Fulgent Data at ASCO 2023 Highlights Progress for FID-007, in Various Cancers
05 Jun 2023 //
BUSINESSWIRE
Fulgent Announces Upcoming Presentation of Data for FID-007 at ASCO
18 May 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.